《Table 1:Baseline characteristics of patients receiving placebo treatment compared between Asian pop
提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《亚洲与欧美人群2型糖尿病患者的安慰剂效应比较(英文)》
Moreover,there were eight studies in Asian population and 33 studies in Caucasian population with GLP?1RAtreatment compared with placebo[Supplementary Tables S1 and S2].Baseline characteristics of the patients received placebo treatment in different studies are shown in Table 1.Baseline BMI was significantly different between Asian and Caucasians in the treatment of AGIs,TZDs,DPP?4i,SGLT2i,and GLP?1RAs,but not in the treatment of MET.Other characteristics such as baseline age,gender,duration of diabetes,and baseline HbA1c were comparable between Asian and Caucasian populations in most kinds of antidiabetic treatment.
图表编号 | XD0027954400 严禁用于非法目的 |
---|---|
绘制时间 | 2018.07.05 |
作者 | Wei Guo、Lin Nie、XiRui Wang、MeiLing Xu、WenJia Yang、XueYing Gao、XiaoLing Cai、LiNong Ji |
绘制单位 | Department of Emergency,Peking University People's Hospital、Department of Endocrinology and Metabolism,Beijing Airport Hospital、Department of Endocrinology and Metabolism,Beijing Airport Hospital、Department of Endocrinology and Metabolism,Beijing Airport |
更多格式 | 高清、无水印(增值服务) |
查看“Table 1:Baseline characteristics of patients receiving placebo treatment compared between Asian population and Caucasian”的人还看了
- Table 1 Baseline characteristics according to the frequency of carbonated beverages consumption in male
- Table 1 Baseline characteristics of patients with and without post-admission progression to hepatic decompensation